Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report

RATIONALE: Apatinib is a novel anti-angiogenic agent that targets vascular endothelial growth factor receptor-2, thereby inhibiting tumor angiogenesis, and is effective in the treatment of brain metastases (BM) and peritumoral brain edema (PTBE). There are no previous reports of combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Hongxia, Li, Xiaolu, Peng, Yi, Zhang, Pingping, Zou, Ning, Liu, Xiyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581043/
https://www.ncbi.nlm.nih.gov/pubmed/33120847
http://dx.doi.org/10.1097/MD.0000000000022925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581043/
https://www.ncbi.nlm.nih.gov/pubmed/33120847
http://dx.doi.org/10.1097/MD.0000000000022925

Ejemplares similares